• Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Families
  • Healthcare Professionals
  • Science
    • Pipeline
    • IBP-9414
    • IBP-1016
    • Publications
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Families
  • Healthcare Professionals
  • Science
    • Pipeline
    • IBP-9414
    • IBP-1016
    • Publications
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career

Press releases


Infant Bacterial Therapeutics publishes Annual Report for 2021 in XHTML format

On March 31 2022 IBT published the 2021 annual report in the format of a PDF file. Today, IBT publish the same report in the XHTML format. The content of the report has not been changed.

see link,
https://ibtherapeutics.com/investors/financial-reports/

For more information contact

Staffan Strömberg, VD

Maria Ekdahl, CFO

Attachment

  • Annual Report 2021

January 27, 2023

Latest press releases

Infant Bacterial Therapeutics publishes Annual Report for 2022
Infant Bacterial Therapeutics’ (IBT) opening of a final infant cohort will accelerate patient recruitment
Infant Bacterial Therapeutics AB (publ) Interim report January 1- December 31, 2022
Infant Bacterial Therapeutics publishes Annual Report for 2021 in XHTML format
Infant Bacterial Therapeutics’ (IBT) publishes clinical findings in the British Journal of Gastroenterology on the convincing association of clinical events to the feeding primary endpoint of the ‘Connection Study’
This site uses cookies – small text-based files that are placed on your device to help us provide a better user experience. Find out more.
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2023
Cookie Policy Privacy Policy Terms of Use